COVID-19: Enrichment and analysis of rare antigen- and virus-specific T cells

Recorded webinar

Analysis of antigen- and virus-specific T cells is essential to the understanding of fundamental immunological processes in the contexts of e.g. infectious diseases, immuno-oncology, as well as immune tolerance. 
 
However, working with antigen- and virus-specific T cells poses several challenges to researchers. Their low frequencies often hamper a reliable analysis. Specificity, inflammatory environment, subtype as well as detection limit and background are determining factors and thus require optimized procedures in order to facilitate a successful experiment.  
 
Our enrichment and analysis solutions are perfectly suited for the examination of rare antigen- and virus-specific T cells and will assist you in even the most challenging research projects and your work on viral threats like SARS-CoV-2. 
 
It’s all about finding the needle in the haystack! 

video preview Play video

COVID-19: Enrichment and analysis of rare antigen- and virus-specific T cells

See how to beat the challenges that working with antigen- and virus-specific T cells in immunological research pose, specifically in SARS-CoV-2 and COVID-19 research.

About the presenter

Marcello Stein Ph.D. received his doctoral degree in immunology from the University of Erlangen-Nuremberg, Germany in 2011. After two years of post-doctoral studies at the Department of Immune Modulation at the University Hospital Erlangen, and three years as Product Manager Life Science at Peqlab Biotechnologie GmbH and VWR International AG, Dr. Stein joined Miltenyi Biotec as Global Product Manager and Group Leader Immunology T cells in the marketing department. His team focuses primarily on the T cell research product portfolio and covers amongst others workflows for CAR T cell research, antigen-specific T cells and regulatory T cells. 

Marcello Stein, Miltenyi Biotec